Inventors:
Momar Ndao - La Prairie, CA
Brian Ward - Montreal, CA
Peter Krause - Hartford CT, US
Mark W. Duncan - Denver CO, US
Mike Edwards - Denver CO, US
Terence William Spithill - Notre Dame D'lle Perrot, CA
International Classification:
G01N 33/569
Abstract:
The present invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying babesia status in a patient. In particular, the biomarkers of this invention are useful to classify a subject sample as infected with babesia or not infected with babesia. The biomarkers can be detected by SELDI mass spectrometry.